Article Versions Notes

Bernard A, Mroué M, Bourthoumieu S, Boyce M, Richard L, Sturtz F, Demiot C, Danigo A. Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice. Pharmaceuticals. 2024; 17(2):144. https://doi.org/10.3390/ph17020144

Bernard, Amandine, Mohamad Mroué, Sylvie Bourthoumieu, Malcolm Boyce, Laurence Richard, Franck Sturtz, Claire Demiot, and Aurore Danigo. 2024. "Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice" Pharmaceuticals 17, no. 2: 144. https://doi.org/10.3390/ph17020144

Bernard, A., Mroué, M., Bourthoumieu, S., Boyce, M., Richard, L., Sturtz, F., Demiot, C., & Danigo, A. (2024). Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice. Pharmaceuticals, 17(2), 144. https://doi.org/10.3390/ph17020144